Dec 16 (Reuters) - South Korea-based ADEL said late on Monday that it has entered a $1.04 billion partnership with French drugmaker Sanofi to develop and sell the biotech company's experimental ...
PHOENIX — In a pair of interviews with separate news outlets, Maricopa County Attorney Allister Adel further distanced herself from a set of controversial gang charges that were hanging over a group ...
SEOUL, South Korea, Dec. 15, 2025 /PRNewswire/ -- ADEL, Inc., a biopharmaceutical company dedicated to developing therapies for neurodegenerative diseases such as Alzheimer's Disease, today announced ...
Korean biopharmaceutical company Adel announced Monday that it has secured a license-out agreement worth up to $1.04 billion with multinational health care firm Sanofi for the development and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results